Study to Assess the Efficacy and Safety of Orismilast in Psoriasis
Public ClinicalTrials.gov record NCT05190419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of Orismilast in Adults With Moderate-to-Severe Plaque-Type Psoriasis
Study identification
- NCT ID
- NCT05190419
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- UNION therapeutics
- Industry
- Enrollment
- 202 participants
Conditions and interventions
Conditions
Interventions
- Orismilast modified release tablets Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 29, 2021
- Primary completion
- Nov 23, 2022
- Completion
- Dec 19, 2022
- Last update posted
- Apr 15, 2024
2021 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Connecticut Dermatology | Cromwell | Connecticut | 06416 | — |
| GWU MFA | Washington D.C. | District of Columbia | 20037 | — |
| ALLCUTIS Research, LLC | Beverly | Massachusetts | 01915 | — |
| ALLCUTIS Research, LLC | Portsmouth | New Hampshire | 03801 | — |
| Bruce E. Katz, MD | New York | New York | 10022 | — |
| Sadick Research Group LLC | New York | New York | 10075 | — |
| Apex Clinical Research Center | Mayfield Heights | Ohio | 44124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05190419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05190419 live on ClinicalTrials.gov.